Medicine: Tree frog hope for Alzheimer's
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.A South American tree frog is helping British chemists develop a super-painkiller that may also offer hope to sufferers of Alzheimer's disease. The scientists are copying the molecular structure of a poison secreted from the skin of the brightly coloured tree frog Epipedobates tricolor.
Using the natural substance epibatidine as a starting point they have created designer compounds with enormous medical potential.
John Malpass and his team from the University of Leicester are co-operating with a major drug company on the research, which holds out the possibility of producing a painkiller 200 times more powerful than morphine but without the usual side-effects.
Because it works in an entirely different way from morphine and other opiates it may also provide an effective treatment for Alzheimer's disease, by boosting memory.
Naturally occurring epibatidine cannot be used because it is so toxic. But it is possible to create safe compounds by copying its chemical structure and modifying it and combining it with other molecules.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments